Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies.

Bansal VV, Godfrey EL, Sadjadi J, Bello RJ, Kwakman R, Abreu AA, Vudatha V, Sparkman BK, Freudenberger DC, Su DG, Turaga KK, Micic D, Malec M, Tun S, Polite B, Lambert LA, Greenbaum A, Gunderson CG, Smith TJ, Kopecky KE, Powers BD, Maduekwe UN, Ward EP, Peritoneal Surface Malignancies (PSM) Consortium Group

Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms.

Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A, Peritoneal Surface Malignancies (PSM) Consortium Group

Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement.

Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Cusack J, Winer JH, Gunderson CG, Misdraji J, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Foote MB, Peritoneal Surface Malignancies (PSM) Consortium Group

Indocyanine green (ICG) imaging: case report of innovative isthmocele diagnosis and repair in a post-ablation patient and literature review.

Tam T, Mabini C, Fernandez CM, Levine EM

Cognitive load in hospital medicine: Implications for teachers, learners, and programs.

Levine EM, Olson APJ, Ratcliffe T, McBee E

Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus.

Bhatt A, Stepanyan A, Moran BJ, Chi D, Fotopoulou C, Baumgartner JM, Bakrin N, Deraco M, Ferron G, Kepenekian V, Kusamura S, Lavoue V, Al Niaimi A, Arjona-Sanchez A, Sehouli J, Sukumar V, Turaga K, Villeneuve L, Planchamp F, Zapardiel GutiĂŠrrez I, Brennan DJ, Glehen O, PSOGI-ESGO-ISSPP Collaborators

Model-based characterization of total serum bilirubin dynamics in preterm infants.

Chen M, BeuchĂŠe A, Levine E, Storme L, Gascoin G, HernĂĄndez AI

Using prognostic signatures and machine learning to identify core features associated with response to CDK4/6 inhibitor-based therapy in metastatic breast cancer.

Witkiewicz AK, Wang J, Schultz E, O'Connor TN, O'Connor T, Levine E, Knudsen ES

Editorial Self-Publication in Plastic Surgery Journals.

Levine E, Lineaweaver W, Drolet B

Co-therapy with S1P and heparan sulfate derivatives to restore endothelial glycocalyx and combat pro-atherosclerotic endothelial dysfunction.

Mitra R, Pentland K, Kolev S, Eden M, Levine E, Oakes JM, Ebong EE

Racism as a modifiable risk factor.

Levine EM

Guidelines for the Prophylaxis and Treatment of Peritoneal Metastases From Colorectal Cancer: A GRADE-Approach for Evidence Evaluation and Recommendations.

GoĂŠrĂŠ D, Kusamura S, Lurvink RJ, Cinquini M, Piso P, Levine E, Hubner M, CortĂŠs Guiral D, Brandl A, Spinelli A, De Hingh IHJT, Deraco M

Outcomes for Gastrectomy During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongastric Primaries: 30-Year Experience.

Cos H, Russell G, Perry K, Votanopoulos KI, Levine EA, Shen P

NCCN GuidelinesÂŽ Insights: Testicular Cancer, Version 2.2025.

Gilligan T, Lin DW, Adra N, Bagrodia A, Feldman DR, Yamoah K, Aggarwal R, Chandrasekar T, Costa D, Drakaki A, Eggener S, Emamekhoo H, Geynisman DM, Graham L, Humphrey P, Leuva H, Levine EG, Luckenbaugh A, Maughan BL, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Reichert Z, Rwigema JC, Saylor P, Shah A, Shah S, Singla N, Sircar K, VanderWeele D, Zhumkhawala A, Montgomery S, Sliker B

ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, a Likely Common Practice but Infrequently Reported.

Mangieri CW, Levine EA